SEP-228425

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSEP-228425
Drug Alias NameSEP-225425SEP-228425
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsAdrenergic receptors antagonistsDopamine reuptake inhibitors
TargetsDopamine transporterAdrenergic receptorsSerotonin transporter
Therapy Area/IndicationsDepressionPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Dainippon
Active IndicationsN/A
Inactive IndicationsDepressionPain

Other Information

ATC CodeN/A
Related LinksN/A